AIDS, HIV & STDs Market Research Reports & Industry Analysis
HIV (human immunodeficiency virus) is a virus that attacks the immune system, making it difficult for the body to fight off infection and diseases. HIV infection eventually results in AIDS (acquired immunodeficiency syndrome). This conversion to AIDS may result after 12 or 13 years after the initial infection. Initial HIV symptoms are similar to those of the flu and include fatigue, fever, weight loss, and swollen lymph nodes in the neck, armpits, or groin. Although there is currently no cure for HIV infection, a combination of medications called Highly Active AntiRetroviral Therapy (HAART), and now referred to as AART, helps prolong life in many people. As noted above, person with HIV infection may live for many years before developing any signs of AIDS.
While HIV/AIDS isn’t found in the headlines as much as during the disease’s discovery, more people in the United States are living with HIV/AIDS than ever before. While the incidence of HIV infection in the United States was approximately 0.25% of the population ten to fifteen years ago, it is now approximately 0.47% -- and the population in general has grown.
For this reason, it is important to understand the trends in HIV/AIDS epidemiology and the potential impacts on economies and societies as a whole. These trends emphasize the strategic need for preventive approaches, clinical testing technologies and products, and new therapeutics. Many market research reports provide such information.
AIDS, HIV & STDs Industry Research & Market Reports
-
Global Sexually Transmitted Diseases (STD) Treatment Market 2024-2028
... report on the sexually transmitted diseases (Std) treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
2024-2028 Global Herpes Testing (Simplex I/II, Type VI) in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Regions and Countries Asia-Pacific Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, ... Read More
-
Anal Fistula Treatment
... by 2030, growing at a CAGR of 4.2% over the analysis period 2023-2030. The U.S. Market is Estimated at US$197.9 Million While China is Forecast to Grow at 4.1% CAGR The Anal Fistula Treatment market ... Read More
-
Herpes Marker Testing
... by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Diagnostic Centers End-Use, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$279.9 Million ... Read More
-
Sexually Transmitted Diseases (STDs) Drug
... Billion by 2030, growing at a CAGR of 9.4% over the analysis period 2023-2030. HPV Disease Drugs, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$74.3 ... Read More
-
Gonorrhea (GN): Competitive Landscape
... the 16 countries covered in GlobalData’s epidemiology forecast. Currently, the GN market contains many innovative therapies developed by big pharma giants. R&D efforts for GN are limited. Currently, 33 molecules are in the pipeline, with ... Read More
-
C-X-C Chemokine Receptor 4 (CXCR4) Antagonists Global Market Report 2024 Including: 1) By Type: BL-8040; GMI-1359; Plerixafor (AMD3100); Balixafortide (POL6326); USL311; Burixafor (GPC-100) 2) By Route Of Administration: Oral; Injectable 3) By Product Pipeline: Approved; Clinical Trials; Pre-Clinical 4) By Application: Cancer; Human Immunodeficiency Virus (HIV); Chronic Inflammatory Disease; Stem Cell Mobilization; Immune And Autoimmune Diseases 5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies Covering: Pfizer Inc.; F-Hoffmann La Roche Ltd.; Sanofi; Bristol-Myers Squibb Company; AstraZeneca plc
... Pre-Clinical4) By Application: Cancer; Human Immunodeficiency Virus (HIV); Chronic Inflammatory Disease; Stem Cell Mobilization; Immune And Autoimmune Diseases5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online PharmaciesCovering: Pfizer Inc.; F-Hoffmann La Roche Ltd.; Sanofi; Bristol-Myers ... Read More
-
HIV Point of care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
... Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the HIV Point of care (POC) Tests pipeline products with comparative analysis of the ... Read More
-
Chlamydia Infection Treatment Global Market Report 2024 Including: 1) By Treatment: Chlamydia Culture; Urine Culture; Enzyme Immunoassays; Nucleic Acid Amplification Test 2) By Causative Organisms: Chlamydia Trachomatis; Chlamydophila Pneumoniae 3) By Route Of Administration: Oral; Injectables 4) By End-Users: Hospitals; Homecare; Specialty Clinics Covering: Pfizer Inc.; F. Hoffmann La-Roche Ltd; Merck & Co. Inc.; AbbVie Inc; Sanofi S.A.
... End-Users: Hospitals; Homecare; Specialty Clinics Covering: Pfizer Inc.; F. Hoffmann La-Roche Ltd; Merck & Co. Inc.; AbbVie Inc; Sanofi S.A. Chlamydia Infection Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers ... Read More
-
Global Herpes Marker Testing Market Growth (Status and Outlook) 2024-2030
... demand in downstream market, the Herpes Marker Testing is forecast to a readjusted size of US$ 92 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential ... Read More
-
Global Herpes Zoster Infection Treatment Market Growth (Status and Outlook) 2024-2030
... growing demand in downstream market, the Herpes Zoster Infection Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth ... Read More
-
Global Treatment and Prevention of Herpes Labialis Market Growth (Status and Outlook) 2024-2030
... 1168.4 million in 2023. With growing demand in downstream market, the Treatment and Prevention of Herpes Labialis is forecast to a readjusted size of US$ 1574.9 million by 2030 with a CAGR of 4.4% during ... Read More
-
Global Sexually Transmitted Disease (STD) Testing Market 2024-2028
... report on the sexually transmitted disease (STD) testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
Genital Herpes Global Market Report 2024
... ; AbbVie Inc.; Sanofi SA Genital Herpes Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. This report focuses ... Read More
-
HIV Drugs Market
... 2024 to USD 58.24 billion by 2032, exhibiting a CAGR of 6.2% during the forecast period of 2024-2032. This led to the decline of the market because of the disruptions in the supply chain of ... Read More
-
Global Human Anti-Herpes Simplex Virus Type 1 ELISA Kit Market Growth 2024-2030
... US$ million in 2023. With growing demand in downstream market, the Human Anti-Herpes Simplex Virus Type 1 ELISA Kit is forecast to a readjusted size of US$ million by 2030 with a CAGR of % ... Read More
-
Global Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Market Growth 2024-2030
... US$ million in 2023. With growing demand in downstream market, the Human Anti-Herpes Simplex Virus Type 2 ELISA Kit is forecast to a readjusted size of US$ million by 2030 with a CAGR of % ... Read More
-
2024 Global Sexually-Transmitted Disease (STD) Testing Market: US, Europe, Japan - Supplier Shares and Sales Segment Forecasts by Country - Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis
... and provides analysis of the global sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. Please note: The delivery time for the electronic ... Read More
-
2024 Global Chlamydia Diagnostics Market: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies
... US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Chlamydia definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the ... Read More
-
2024 Global HIV/AIDS Diagnostics Market: US, Europe, Japan - Supplier Shares, Volume and Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies
... in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses are reviewed. The report provides the 5-year test volume and ... Read More
-
2024 Global Gonorrhea Diagnostics Market: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies
... US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Gonorrhea definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the ... Read More
-
2024 Global Syphilis Diagnostics Market: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies
... US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Syphilis definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the ... Read More
-
2024 Europe Sexually-Transmitted Disease (STD) Testing Market: France, Germany, Italy, Spain, UK - Supplier Shares and Sales Segment Forecasts - Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis-
... the European sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. The report presents detailed analysis of the STD market in Europe (France, ... Read More
-
2024 Global Herpes Diagnostics Market: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies
... US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Herpes definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for Herpes ... Read More
-
2024 France Sexually-Transmitted Disease (STD) Market: Shares and Segment Forecasts - AIDS/HIV, Chancroid, Chlamydia, Gonorrhea, Granuloma Inguinale, Herpes I/II, Lymphogranuloma, Mycoplasma, Papillomavirus, Syphilis, Trichomonas Vaginalis
... analysis of the French STD market. Current scientific views on epidemiology and etiology are presented for: AIDS/HIV Chancroid Chlamydia Gonorrhea Granuloma Inguinale Herpes I/II Lymphogranuloma Mycoplasma Papillomavirus Syphilis Trichomonas Vaginalis The report provides test volume ... Read More
Research Assistance
